Impact of changes in neurotrophic supplementation on development of Alzheimer’s disease-like pathology in OXYS rats
- 11 March 2017
- journal article
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 82 (3) , 318-329
Abstract
Alzheimer’s disease (AD) is the most common type of age-related dementia. The development of neurodegeneration in AD is closely related to alterations in neurotrophic supplementation of the brain, which may be caused either by disorder of neurotrophin metabolism or by modification of its availability due to changes in the microenvironment of neurons. The underlying mechanisms are not fully understood. In this work, we used senescence-accelerated OXYS rats as a unique model of the sporadic form of AD to examine the relationship of development of AD signs and changes in neurotrophic supplementation of the cortex. Based on comparative analysis of the transcriptome of the frontal cerebral cortex of OXYS and Wistar (control) rats, genes of a neurotrophin signaling pathway with different mRNA levels in the period prior to the development of AD-like pathology in OXYS rats (20 days) and in the period of its active manifestation (5 months) and progression (18 months) were identified. The most significant changes in mRNA levels in the cortex of OXYS rats occurred in the period from 5 to 18 months of age. These genes were associated with neurogenesis, neuronal differentiation, synaptic plasticity, and immune response. The results were compared to changes in the levels of brain-derived neurotrophic factor (BDNF), its receptors TrkB and p75NTR, as well as with patterns of their colocalization, which reveal the balance of proneurotrophins and mature neurotrophins and their receptors. We found that alterations in neurotrophic balance indicating increased apoptosis precede the development of AD-like pathology in OXYS rats. Manifestation of AD-like pathology occurs against a background of activation of compensatory and regenerative processes including increased neurotrophic supplementation. Active progression of AD-like pathology in OXYS rats is accompanied by the suppression of activity of the neurotrophin system. Thus, the results confirm the importance of the neurotrophin system as a potential target for development of new approaches to slow age-related alterations in brain and AD development.Keywords
This publication has 23 references indexed in Scilit:
- Senescence-accelerated OXYS rats: A model of age-related cognitive decline with relevance to abnormalities in Alzheimer diseaseCell Cycle, 2014
- Neurotrophins in the Regulation of Cellular Survival and Death2014
- NGF, BDNF, NT3, and NT42014
- Death of developing neurons: New insights and implications for connectivityJournal of Cell Biology, 2013
- The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Propagation of Tau Pathology in a Model of Early Alzheimer's DiseaseNeuron, 2012
- Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene ExpressionJournal of Neuroscience, 2009
- Alzheimer's Disease: From Pathology to Therapeutic ApproachesAngewandte Chemie International Edition, 2009
- β-Amyloid1–42Induces Neuronal Death through the p75 Neurotrophin ReceptorJournal of Neuroscience, 2008
- Role of p75 Neurotrophin Receptor in the Neurotoxicity by β-amyloid Peptides and Synergistic Effect of Inflammatory CytokinesJournal of Experimental Medicine, 2002